Belluscura has developed the X-PLOR, a lightweight, portable oxygen delivery device aimed at treating the millions of people globally suffering from chronic lung diseases. The company plans to launch this novel and cost-effective device in the US in 2019, with Europe to follow.
Tekcapital investee Belluscura eyes raising GBP17.5 million in AIM IPO Morning Star |
21/05/2021 |
Intention to float - AIM London Stock Exchange |
07/05/2021 |
Medical device firm Belluscura has revealed plans for a London float CityAM |
16/11/2017 |
Belluscur plans London float CityAM |
16/11/2017 |
Acquisition for medical device company Insider Media |
27/04/2017 |
09910883
10/12/2015
Active
Manufacture of consumer electronics
7
Date | Amount | No. of Investors | |
---|---|---|---|
23/04/2019 | £538,140 | 302 | View |
2019 | 2020 | |
---|---|---|
Turnover | £90.98k | £0 |
Cash | £730.6k | £367.64k |
Increase in Cash | £331.94k | £-376.28k |
Financial data drawn from last filed accounts don't necessarily reflect current trading activity.
Name | Role | Appointed | Nationality |
---|---|---|---|
DYER, Anthony Stephen | Secretary | 17/11/2017 | British |
DYER, Anthony Stephen | Director | 17/11/2017 | British |
PIPER, Richard John | Director | 21/05/2021 | British |
POUTNEY, David John | Director | 21/05/2021 | British |
RAUKER, Robert | Director | 16/08/2016 | American |
REYNOLDS, Adam | Director | 21/04/2021 | British |
STROLLO, Patrick | Director | 21/04/2021 | American |